
Ardelyx Inc is a biotechnology business based in the US. Ardelyx shares (ARDX) are listed on the NASDAQ and all prices are listed in US Dollars. Ardelyx employs 86 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Ardelyx
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ARDX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Ardelyx stock price (NASDAQ: ARDX)
Use our graph to track the performance of ARDX stocks over time.Ardelyx shares at a glance
Latest market close | $0.61 |
---|---|
52-week range | $0.49 - $8.25 |
50-day moving average | $0.68 |
200-day moving average | $0.96 |
Wall St. target price | $6.14 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.36 |
Buy Ardelyx shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Ardelyx stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ardelyx price performance over time
Historical closes compared with the close of $0.6113 from 2022-07-05
1 week (2022-06-29) | 6.31% |
---|---|
1 month (2022-06-02) | N/A |
3 months (2022-04-06) | -43.40% |
6 months (2022-01-02) | N/A |
1 year (2021-07-06) | -92.52% |
---|---|
2 years (2020-07-06) | -91.36% |
3 years (2019-07-05) | 2.7 |
5 years (2017-07-05) | 5.2 |
Ardelyx financials
Revenue TTM | $4 million |
---|---|
Gross profit TTM | $5 million |
Return on assets TTM | -55.25% |
Return on equity TTM | -157.01% |
Profit margin | 0% |
Book value | $0.47 |
Market capitalisation | $85.9 million |
TTM: trailing 12 months
Ardelyx share dividends
We're not expecting Ardelyx to pay a dividend over the next 12 months.
Ardelyx share price volatility
Over the last 12 months, Ardelyx's shares have ranged in value from as little as $0.49 up to $8.247. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ardelyx's is 1.8544. This would suggest that Ardelyx's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ardelyx overview
Ardelyx, Inc. , a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc.
Ardelyx in the news
Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022
Frequently asked questions
What percentage of Ardelyx is owned by insiders or institutions?Currently 1.853% of Ardelyx shares are held by insiders and 28.751% by institutions. How many people work for Ardelyx?
Latest data suggests 86 work at Ardelyx. When does the fiscal year end for Ardelyx?
Ardelyx's fiscal year ends in December. Where is Ardelyx based?
Ardelyx's address is: 400 Fifth Avenue, Waltham, MA, United States, 02451 What is Ardelyx's ISIN number?
Ardelyx's international securities identification number is: US0396971071 What is Ardelyx's CUSIP number?
Ardelyx's Committee on Uniform Securities Identification Procedures number is: 039697107
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert